Earthmeta Earthmeta

Tesla CEO Elon Musk Tests Both Positive and Negative to COVID-19

| Updated
by Ibukun Ogundare · 3 min read
Tesla CEO Elon Musk Tests Both Positive and Negative to COVID-19
Photo: Shutterstock

Tesla CEO Elon Musk was tested for COVID-19. The results turned out to be controversial.

SpaceX founder and CEO of Tesla Inc (NASDAQ: TSLA) Elon Musk has tested both negative and positive to COVID-19. Musk announced the test results on the 12th of November in a tweet.

Referring to the occurrence as “extremely bogus,” he said:

“Was tested for covid four times today. Two tests came back negative, two came back positive. Same machine, same test, same nurse. Rapid antigen test from BD.”

A Reuters report stated that by “BD,” the Tesla CEO may be referring to Becton, Dickinson and Company (NYSE: BDX) rapid antigen test.

In response to a Twitter user who asked him if he has any symptoms of COVID-19, Musk said:

“Symptoms of a typical cold. Nothing unusual so far.”

Musk further said that he is getting PCR (Polymerase Chain Reaction) tests from other labs and await results in about 24 hours. 

American multinational medical technology company Becton Dickinson is notably one of the major companies supplying COVID-19 antigen tests. Before now, the company said it was carrying out investigations on reports from US nursing homes that its testing equipment was processing fake-positive results. 

Global Efforts on COVID-19 Vaccine

Many, both individuals and organizations, have been making efforts to fight the unprecedented global health crisis. Several pharmaceutical companies are working towards an effective vaccine through individual and joint forces. Also, billionaires, foundations, and even the government have been financially supporting the fight.

Recently, the Gates Foundation committed an additional $70 million to fast-track the development and distribution of coronavirus vaccines. In total, the private foundation has pledged $156 million. The Gates Foundation co-founder Melinda Gates mentioned the purpose of the financial commitments. Melinda said it is to ensure that everyone globally has equal and fair access to coronavirus tests, drugs, and vaccines. 

Pfizer Inc (NYSE: PFE) and BioNtech SE (NASDAQ: BNTX) have been working relentlessly to jointly produce a coronavirus vaccine. The joint venture has now announced that its mRNA-based vaccine candidate, BNT162b2, has proven to be 90% effective. 

Notably, the European Union has finalized a deal with BioNTech and Pfizer to purchase up to 300 million doses of coronavirus vaccine.

Pfizer Inc is currently trading at $38.09, a 1.44% increase over its previous close of $37.55. The drug-maker also added 0.72% in the last twelve months and over 3% in the last five days. However, Pfizer is down 4.16% in its year-to-date record. The pharmaceutical company has also lost 1.34% over the last three months and 1.05% in the past month. 

On the other hand, the German biotechnology company, BioNTech, has been surging all year. The company has gained 434.89% in the last one year and nearly 200% in its year-to-date. Also, the German company has jumped 43.145 over the last three months. In addition, BNTX increased by 12.45% in the past month and 10.47% in the last five days. 

Business News, Editor's Choice, Market News, News
Related Articles